£7.2Billion!!9 Nov 2022 10:13
“We have developed a proprietary library of 427 synthetic cannabinoid derivatives and around 14 patent families, providing a source for further drug candidates to enter our pipeline.“
“NED - Richard is Corporate Development Director at Imperial Brands plc, where he is responsible for leading corporate development and M&A activity as well as other strategic initiatives and projects across the business. Prior to joining Imperial, Richard was a partner at KPMG.”
https://www.oxcantech.com/board